Distinctive Acne Entities

  • Gerd Plewig
  • Bodo Melnik
  • WenChieh Chen


We generally think of acne as a disease which begins in adolescence. Its presentation in the neonatal period or during infancy is disturbing but rarely serious. The following synopsis of acne shows the great spectrum of acne diversities and variations.


Acne in Newborn, Infancy and Childhood

  1. Ayres S. Infantile acne vulgaris. Arch Dermatol Syph. 1926;14:12–3.CrossRefGoogle Scholar
  2. Bekaert C, Song M, Delvigne A. Acne neonatorum and familial hyperandrogenism. Dermatology. 1998;196:453–4.CrossRefGoogle Scholar
  3. Bustamante C, Hoyos-Martínez A, Pirela D, Díaz A. In utero virilization secondary to a maternal Krukenberg tumor: case report and review of literature. J Pediatr Endocrinol Metab. 2017;30:785–90.CrossRefGoogle Scholar
  4. Caputo R, Monti M, Ermacora E, Carminati G, et al. Cutaneous manifestations of tetrachlorodibenzo-p-dioxin in children and adolescents: follow-up 10 years after the Seveso, Italy, accident. J Am Acad Dermatol. 1988;19:812–9.CrossRefGoogle Scholar
  5. Chew EW, Bingham A, Burrows D. Incidence of acne vulgaris in patients with infantile acne. Clin Exp Dermatol. 1990;15:376–7.CrossRefGoogle Scholar
  6. Eichenfield LF, Krakowski AC, Piggott C, Del Rosso J, et al. American Acne and Rosacea Society. Evidence-based recommendations for the diagnosis and treatment of pediatric acne. Pediatrics. 2013;131(Suppl 3):S163–86.CrossRefGoogle Scholar
  7. Hernández-Martín Á, Nuño-González A, Colmenero I, Torrelo A. Eosinophilic pustular folliculitis of infancy: a series of 15 cases and review of the literature. J Am Acad Dermatol. 2013;68:150–5.CrossRefGoogle Scholar
  8. Hızlı D, Köşüş A, Köşüş N, Kamalak Z, et al. The impact of birth weight and maternal history on acne, hirsutism, and menstrual disorder symptoms in Turkish adolescent girls. Endocrine. 2012;41:473–8.CrossRefGoogle Scholar
  9. Jansen T, Burgdorf WHC, Plewig G. Pathogenesis and treatment of acne in childhood. Pediatr Dermatol. 1997;14:17–21.CrossRefGoogle Scholar
  10. Lucky AW, Biro FM, Huster GA, Leach AD, et al. Acne vulgaris in premenarchal girls: an early sign of puberty associated with rising levels of dehydroepiandrosterone. Arch Dermatol. 1994;130:308–14.CrossRefGoogle Scholar
  11. Lucky AW, Biro FM, Huster GA, Morrison JA, et al. Acne vulgaris in early adolescent boys. Arch Dermatol. 1991;127:210–6.CrossRefGoogle Scholar
  12. Lucky AW, Biro FM, Simbartl LA, Morrison JA, et al. Predictors of severity of acne vulgaris in young adolescent girls—results of a five-year longitudinal study. J Pediatr. 1997;130:30–9.CrossRefGoogle Scholar
  13. Nanda A, Kaur S, Bhakoo ON, Kapoor MM, et al. Fetal hydantoin syndrome: a case report. Pediatr Dermatol. 1989;6:130–3.CrossRefGoogle Scholar
  14. Neely EK, Crossen SS. Precocious puberty. Curr Opin Obstet Gynecol. 2014;26:332–8.CrossRefGoogle Scholar
  15. Rapelanoro R, Mortureux P, Couprie B, Maleville J, et al. Neonatal Malassezia furfur pustulosis. Arch Dermatol. 1996;132:190–3.CrossRefGoogle Scholar
  16. Stewart ME, Downing DT, Cook JS, Hansen JR, et al. Sebaceous gland activity and serum dehydroepiandrosterone sulfate levels in boys and girls. Arch Dermatol. 1992;128:1345–8.CrossRefGoogle Scholar
  17. Verrotti A, D’Egidio C, Coppola G, Parisi P, et al. Epilepsy, sex hormones and antiepileptic drugs in female patients. Expert Rev Neurother. 2009;9:1803–14.CrossRefGoogle Scholar
  18. Voutilainen R, Jääskeläinen J. Premature adrenarche: etiology, clinical findings, and consequences. J Steroid Biochem Mol Biol. 2015;145:226–36.CrossRefGoogle Scholar
  19. Zander J, Mickan H, Holzmann K, Lohe KJ. Androluteoma syndrome of pregnancy. Am J Obstet Gynecol. 1978;130:170–7.CrossRefGoogle Scholar

Adult Acne

  1. Carmina E, Godwin AJ, Stanczyk FZ, et al. The association of serum androsterone glucuronide with inflammatory lesions in women with adult acne. J Endocrinol Invest. 2002;25:765–8.CrossRefGoogle Scholar
  2. Di Landro A, Cazzaniga S, Cusano F, et al. Adult female acne and associated risk factors: results of a multicenter case-control study in Italy. J Am Acad Dermatol. 2016;75:1134–1141.e1.CrossRefGoogle Scholar
  3. Goulden V, McGeown CH, Cunliffe WJ. The familial risk of adult acne: a comparison between first-degree relatives of affected and unaffected individuals. Br J Dermatol. 1999;141:297–300.CrossRefGoogle Scholar
  4. Han XD, Oon HH, Goh CL. Epidemiology of post-adolescence acne and adolescence acne in Singapore: a 10-year retrospective and comparative study. J Eur Acad Dermatol Venereol. 2016;30:1790–3.CrossRefGoogle Scholar
  5. Rademaker M, Wishart JM, Birchall NM. Isotretinoin 5 mg daily for low-grade adult acne vulgaris—a placebo-controlled, randomized double-blind study. J Eur Acad Dermatol Venereol. 2014;28:747–54.CrossRefGoogle Scholar
  6. Shen Y, Wang T, Zhou C, et al. Prevalence of acne vulgaris in Chinese adolescents and adults: a community-based study of 17,345 subjects in six cities. Acta Derm Venereol. 2012;92:40–4.CrossRefGoogle Scholar
  7. Svensson A, Ofenloch RF, Bruze M, et al. Prevalence of skin disease in a population-based sample of adults from five European countries. Br J Dermatol. 2018;178:1111–8.CrossRefGoogle Scholar
  8. Trakakis E, Papadavid E, Dalamaga M, et al. Prevalence of non-classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Greek women with acne: a hospital-based cross-sectional study. J Eur Acad Dermatol Venereol. 2013;27:1448–51.CrossRefGoogle Scholar

Acne and Menstrual Cycle

  1. Boyanova L. Stress hormone epinephrine (adrenaline) and norepinephrine (noradrenaline) effects on the anaerobic bacteria. Anaerobe. 2017;44:13–9.CrossRefGoogle Scholar
  2. Cabeza M, Miranda R. Stimulatory effect of progesterone and 5 beta-progesterone on lipid synthesis in hamster flank organs. Steroids. 1997;62:782–8.CrossRefGoogle Scholar
  3. Evans J, Salamonsen LA. Inflammation, leukocytes and menstruation. Rev Endocr Metab Disord. 2012;13:277–88.CrossRefGoogle Scholar
  4. Kariya Y, Moriya T, Suzuki T, et al. Sex steroid hormone receptors in human skin appendage and its neoplasms. Endocr J. 2005;52:317–25.CrossRefGoogle Scholar
  5. Pochi PE. Acne in premature ovarian failure. Reestablishment of cyclic flare-ups with medroxyprogesterone acetate therapy. Arch Dermatol. 1974;109:556–7.CrossRefGoogle Scholar

Acne in Pregnancy

  1. Bechstein SK, Ochsendorf F. Akne und Rosazea in der Schwangerschaft. Hautarzt. 2017;68:111–9.CrossRefGoogle Scholar
  2. Brown SM, Aljefri KA, Waas R, Hampton PJ. Systemic medications used in treatment of common dermatological conditions: safety profile with respect to pregnancy, breast feeding and content in seminal fluid. J Dermatolog Treat. 2017;16:1–53.Google Scholar
  3. Caimari F, Corcoy R, Webb SM. Cushing’s disease: major difficulties in diagnosis and management during pregnancy. Minerva Endocrinol. 2018;43:435–45.Google Scholar
  4. Dréno B, Blouin E, Moyse D, et al. Acne in pregnant women: a French survey. Acta Derm Venereol. 2014;94:82–3.CrossRefGoogle Scholar
  5. Hakim C, Padmanabhan V, Vyas AK. Gestational hyperandrogenism in developmental programming. Endocrinology. 2017;158:199–212.CrossRefGoogle Scholar
  6. Kaňová N, Bičíková M. Hyperandrogenic states in pregnancy. Physiol Res. 2011;60:243–52.PubMedGoogle Scholar
  7. Meredith FM, Ormerod AD. The management of acne vulgaris in pregnancy. Am J Clin Dermatol. 2013;14:351–8.CrossRefGoogle Scholar
  8. Wadzinski TL, Altowaireb Y, Gupta R, et al. Luteoma of pregnancy associated with nearly complete virilization of genetically female twins. Endocr Pract. 2014;20:e18–23.CrossRefGoogle Scholar
  9. Yang CC, Huang YT, Yu CH, et al. Inflammatory facial acne during uncomplicated pregnancy and post-partum in adult women: a preliminary hospital-based prospective observational study of 35 cases from Taiwan. J Eur Acad Dermatol Venereol. 2016;30:1787–9.CrossRefGoogle Scholar

Peri- and Postmenopausal Acne

  1. Achilli C, Pundir J, Ramanathan P, et al. Efficacy and safety of transdermal testosterone in postmenopausal women with hypoactive sexual desire disorder: a systematic review and meta-analysis. Fertil Steril. 2017;107:475–82.e15.CrossRefGoogle Scholar
  2. Elraiyah T, Sonbol MB, Wang Z, et al. Clinical review: the benefits and harms of systemic testosterone therapy in postmenopausal women with normal adrenal function: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2014;99:3543–50.CrossRefGoogle Scholar
  3. Kligman AM. Postmenopausal acne. Cutis. 1991;47:425–6.PubMedGoogle Scholar
  4. Rothman MS, Wierman ME. How should postmenopausal androgen excess be evaluated? Clin Endocrinol (Oxf). 2011;75:160–4.CrossRefGoogle Scholar
  5. Scheffers CS, Armstrong S, Cantineau AE, et al. Dehydroepiandrosterone for women in the peri- or postmenopausal phase. Cochrane Database Syst Rev. 2015;1:CD011066.PubMedGoogle Scholar

Body Building and Doping Acne

  1. Anderson LJ, Tamayose JM, Garcia JM. Use of growth hormone, IGF-I, and insulin for anabolic purpose: pharmacological basis, methods of detection, and adverse effects. Mol Cell Endocrinol. 2018;464:65–74.CrossRefGoogle Scholar
  2. Boos C, Wulff P, Kujath P, Bruch HP. Medikamentenmißbrauch beim Feizeitsportler im Fitneßbereich. Dtsch Ärztebl. 1998;95:A953–7.Google Scholar
  3. Cengiz FP, Cevirgen Cemil B, Emiroglu N. Acne located on the trunk, whey protein supplementation: is there any association? Health Promot Perspect. 2017;7:106–8.CrossRefGoogle Scholar
  4. Collins P, Cotterill JA. Gymnasium acne. Clin Exp Dermatol. 1995;20:509.CrossRefGoogle Scholar
  5. Dorrell HF, Gee TI. The acute effects different quantities of branched-chain amino acids have on recovery of muscle function. Sports Nutr Ther. 2016;1:115.Google Scholar
  6. Downie MM, Kealey T. Human sebaceous glands engage in aerobic glycolysis and glutaminolysis. Br J Dermatol. 2004;151:320–7.CrossRefGoogle Scholar
  7. Goldman A, Basaria S. Adverse health effects of androgen use. Mol Cell Endocrinol. 2018;464:46–55.CrossRefGoogle Scholar
  8. Guha N, Dashwood A, Thomas NJ, et al. IGF-I abuse in sport. Curr Drug Abuse Rev. 2009;2:263–72.CrossRefGoogle Scholar
  9. Guha N, Cowan DA, Sönksen PH, Holt RI. Insulin-like growth factor-I (IGF-I) misuse in athletes and potential methods for detection. Anal Bioanal Chem. 2013;405:9669–83.CrossRefGoogle Scholar
  10. Hartgens F, Kuipers H. Effects of androgenic-anabolic steroids in athletes. Sports Med. 2004;34:513–54.CrossRefGoogle Scholar
  11. Heydenreich G. Testosterone and anabolic steroids and acne fulminans. Arch Dermatol. 1989;125:571–2.CrossRefGoogle Scholar
  12. Holt RI, Sönksen PH. Growth hormone, IGF-I and insulin and their abuse in sport. Br J Pharmacol. 2008;154:542–56.CrossRefGoogle Scholar
  13. Huang G, Basaria S. Do anabolic-androgenic steroids have performance-enhancing effects in female athletes? Mol Cell Endocrinol. 2018;464:56–64.CrossRefGoogle Scholar
  14. Kraus SL, Emmert S, Schön MP, Haenssle HA. The dark side of beauty: acne fulminans induced by anabolic steroids in a male bodybuilder. Arch Dermatol. 2012;148:1210–2.CrossRefGoogle Scholar
  15. Melnik BC. Androgen abuse in the community. Curr Opin Endocrinol Diabetes Obes. 2009;16:218–23.CrossRefGoogle Scholar
  16. Melnik BC. Evidence for acne-promoting effects of milk and other insulinotropic dairy products. Nestle Nutr Workshop Ser Pediatr Program. 2011;67:131–45.CrossRefGoogle Scholar
  17. Melnik BC. Acne vulgaris: the metabolic syndrome of the pilosebaceous follicle. Clin Dermatol. 2018;36:29–40.CrossRefGoogle Scholar
  18. Melnik B, Jansen T, Grabbe S. Anabolikamissbrauch und Bodybuiding-Akne: eine unterschätzte gesundheitliche Gefährdung. J Dtsch Dermatol Ges. 2007;5:110–7.CrossRefGoogle Scholar
  19. Nicholls AR, Holt RI. Growth hormone and insulin-like growth factor-1. Front Horm Res. 2016;47:101–14.CrossRefGoogle Scholar
  20. Nieschlag E, Vorona E. Mechanisms in endocrinology: medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions. Eur J Endocrinol. 2015;173:R47–58.CrossRefGoogle Scholar
  21. Perez M, Navajas-Galimany L, Antunez-Lay A, Hasson A. When strength turns into disease: acne fulminans in a bodybuilder. An Bras Dermatol. 2016;91:706.CrossRefGoogle Scholar
  22. Pontes Tde C, Fernandes Filho GM, Trindade Ade S, Sobral Filho JF. Incidence of acne vulgaris in young adult users of protein-calorie supplements in the city of João Pessoa—PB. An Bras Dermatol. 2013;88:907–12.CrossRefGoogle Scholar
  23. Pope HG Jr, Wood RI, Rogol A, et al. Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev. 2014;35:341–75.CrossRefGoogle Scholar
  24. Raschka C, Chmiel C, Preiss R, Boos C. Doping bei Freizeitsportlern. Eine Untersuchung in 11 Fitnessstudios in Frankfurt am Main. MMW Fortschr. 2013;155(Suppl 2):41–3.CrossRefGoogle Scholar
  25. Razavi Z, Moeini B, Shafiei Y, Bazmamoun H. Prevalence of anabolic steroid use and associated factors among body-builders in Hamadan, West province of Iran. J Res Health Sci. 2014;14:163–6.PubMedGoogle Scholar
  26. Simonart T. Acne and whey protein supplementation among bodybuilders. Dermatology. 2012;225:256–8.CrossRefGoogle Scholar
  27. Silverberg NB. Whey protein precipitating moderate to severe acne flares in 5 teenaged athletes. Cutis. 2012;90:70–2.PubMedGoogle Scholar
  28. Smit DL, de Ronde W. Outpatient clinic for users of anabolic androgenic steroids: an overview. Neth J Med. 2018;76:167.PubMedGoogle Scholar
  29. Traupe H, von Mühlendahl KE, Braamswig J, Happle R. Acne of the fulminans type following testosterone therapy in three excessive tall boys. Arch Dermatol. 1988;124:414–7.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Gerd Plewig
    • 1
  • Bodo Melnik
    • 2
  • WenChieh Chen
    • 3
  1. 1.Department of Dermatology and AllergyLudwig-Maximilian-University MunichMunichGermany
  2. 2.Department of Dermatology, Environmental Medicine and Health TheoryUniversity of OsnabrückOsnabrückGermany
  3. 3.Department of Dermatology and AllergyTechnical University of MunichMunichGermany

Personalised recommendations